Drs. Wykoff and Modi discuss two cases: a patient who is unhappy with the results of his cataract surgery and a 90-year-old who is seeking cataract clearance.
This activity is supported by an independent medical education grant from Apellis Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Charles C. Wykoff, MD, PhD, FACS
Retina Consultants of Texas
Blanton Eye Institute
Houston Methodist Hospital
Houston, TX
Yasha S. Modi, MD, MHS
Associate Professor of Ophthalmology
Department of Ophthalmology
Director of Tele-Retina
NYU Langone Health
New York, NY
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Charles C. Wykoff, MD, PhD, FACS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: 4DMT, AbbVie, Adverum Biotechnologies, Aerie Pharmaceuticals, Alcon, Annexon, Apellis Pharmaceuticals, AGTC, Arrowhead, Ascidian, Bayer, Bausch + Lomb, Boehringer Ingelheim, Cholgene, Clearside Biomedical, Curacle, Eyebiotech, EyePoint Pharmaceuticals, Foresite, Frontera, Genentech, Gyroscope, Iveric Bio, Janssen, Kato, Kiora, Kodiak Sciences, Merck, Nanoscope, Neurotech, NGM Biopharmaceuticals, Notal Vision, Novartis, Ocular Therapeutix, Ocuphire Pharma, OcuTerra, ONL, Opthea, Oxular, Palatin, PerceiveBio, Perfuse, Ray, RecensMedical, Regeneron, Regenxbio, Resonance, Roche, Sanofi, SciNeuro, Stealth, Surrozen, Suzhou Raymon, Thea Pharma, and Valo. Grant/Research Support: 4DMT, Adverum Biotechnologies, AffaMed, Alexion, Alimera Sciences, Alkahest, Allgenesis, Amgen, Annexin, Annexon, Apellis Pharmaceuticals, AsclepiX Therapeutics, Bayer, Boehringer Ingelheim, Chengdu Kanghong Biotechnology, Clearside Biomedical, Curacle, EyePoint Pharmaceuticals, Gemini, Genentech, Gyroscope, IONIS, iRENIX, Iveric bio, Janssen, Kodiak Sciences, LMRI, McMaster University, Nanoscope, Neurotech, NGM Biopharmaceuticals, Novartis, Ocular Therapeutix, Ocuphire Pharma, OcuTerra, OliX, Ophthotech, Opthea, Oxular, Oxurion, Oyster Point, PerceiveBio, Regeneron, Regenxbio, Rezolute, Roche, SamChunDang Pharm, Sandoz, Shanghai Henlius, UNITY, Verily, and Xbrane.
Yasha S. Modi, MD, MHS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Alimera Sciences, Allergan/AbbVie, Apellis Pharmaceuticals, Carl Zeiss Meditec, DORC, Genentech, Iveric Bio, and Théa Pharma.
The Evolve staff and planners have no financial relationships with ineligible companies.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis Pharmaceuticals.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Thomas Albini, MD
Roger A. Goldberg, MD, MBA
Dean Eliott, MD
Charles C. Wykoff, MD, PhD, FACS
Dean Eliott, MD
Charles C. Wykoff, MD, PhD, FACS
Thomas Albini, MD
Roger A. Goldberg, MD, MBA
